Journal of Infection and Public Health. 2012; 5 (Supp. 1): S50-S60
em Inglês
| IMEMR
| ID: emr-149563
ABSTRACT
Targeting epidermal growth factor receptor [EGFR] is an important treatment option for non-small cell lung cancer [NSCLC]. These targeted therapies have been studied extensively in NSCLC in first line and subsequent lines, including maintenance in empiric fashion or in patients with tumors harboring the EGFR mutations. In this manuscript, we will review in details the evolutions of these targeted therapy in the management of NSCLC.
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
J. Infection Public Health
Ano de publicação:
2012
Similares
MEDLINE
...
LILACS
LIS